Research Unit of Orthopaedic and Trauma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.
Department of Medicine and Surgery, Research Unit of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21, 00128, Roma, Italy.
BMC Musculoskelet Disord. 2022 Sep 30;23(1):889. doi: 10.1186/s12891-022-05849-x.
Shoulder replacement (SR) constitutes the gold standard treatment for severe shoulder diseases, including osteoarthritis, rheumatoid arthritis, complex fractures, avascular necrosis and rotator cuff arthropathy. Although several countries have national registries, there is a lack of epidemiological data on SR. Sharing national statistics and correlating those to other countries could be helpful to compare outcomes and costs internationally. This paper aims to evaluate the trend of hospitalizations for SR (both first implants and revisions of anatomical and reverse prosthesis) in Italy from 2009 to 2019, based on the National Hospital Discharge Reports (S.D.O) provided by the Italian National Health Service (INHS). Moreover, the economic impact on the healthcare system of SR and SR revisions was assessed, providing a statistical prediction for the next ten years.
The data used in this paper were about patients who underwent Total Shoulder Replacement (TSR), Shoulder Hemiarthroplasty (SH) or Revision of shoulder joint replacement (RSR) from 2009 to 2019 in Italy. Information about patients was anonymous and included age, sex, days of hospitalization, procedures and diagnoses codes.
From 2009 to 2019, 73,046 TSR and SH were performed in adult Italian residents, with a cumulative incidence of 13.6 cases per 100,000 adult Italian residents. While, 2,129 revisions of shoulder replacement were performed, with a cumulative incidence of 0.4 cases per 100,000 residents. Overall, females represented the majority of the cases (72.4% of patients who underwent TSR or SH and 59.1% of patients who underwent RSR). From 2009 to 2019, has been assessed an overall cost of 625,638,990€ for TSR or SH procedures in Italy. While, an overall cost of 9,855,141€ for RSR procedures in Italy was calculated.
The incidence of SR and RSR is expected to increase in the following years, constituting a burden for the healthcare systems. Overall, in Italy, the females represented the majority of patients. Further prospective studies on this topic in different countries can be con-ducted to make comparisons.
肩部置换术(SR)是治疗严重肩部疾病的金标准,包括骨关节炎、类风湿关节炎、复杂骨折、缺血性坏死和肩袖关节炎。尽管有几个国家设有国家登记处,但缺乏关于 SR 的流行病学数据。分享国家统计数据并与其他国家进行关联,有助于在国际上比较结果和成本。本文旨在根据意大利国家卫生服务局(INHS)提供的国家住院报告(S.D.O),评估 2009 年至 2019 年意大利因 SR(包括解剖和反向假体的初次植入和翻修)而住院的趋势。此外,还评估了 SR 和 SR 翻修对医疗保健系统的经济影响,并对未来十年进行了统计预测。
本文使用的数据涉及 2009 年至 2019 年在意大利接受全肩关节置换术(TSR)、肩关节半关节置换术(SH)或肩关节置换术翻修术(RSR)的患者。患者信息为匿名,包括年龄、性别、住院天数、手术和诊断代码。
2009 年至 2019 年,意大利成年居民共进行了 73046 例 TSR 和 SH,累积发病率为每 10 万成年意大利居民 13.6 例。同时,进行了 2129 例肩部置换翻修术,累积发病率为每 10 万居民 0.4 例。总体而言,女性占大多数病例(TSR 或 SH 患者中女性占 72.4%,RSR 患者中女性占 59.1%)。2009 年至 2019 年,意大利 TSR 或 SH 手术的总成本估计为 625638990 欧元。同时,计算出意大利 RSR 手术的总成本为 9855141 欧元。
预计未来几年 SR 和 RSR 的发病率将会增加,这将给医疗保健系统带来负担。总体而言,在意大利,女性占大多数患者。可以在不同国家进行关于这个主题的进一步前瞻性研究,以进行比较。